Saguaro Biosciences
Canada
- Quebec City
- 05/06/2024
- Seed
- $3,000,000
Saguaro offers next-generation cell culture products that help scientists improve drug discovery success.
ChromaLive is a first-of-a-kind non-toxic dye. It allows the generation of unique phenotypic signatures from microscopy images of cells, and the quantification of disease-relevant phenotypes like cellular apoptosis, stress, autophagy, and more. With its unique add-and-mix feature, ChromaLive is ideal for automation workflows, live cell painting, 3D cultures, weeks-long kinetic imaging, and patient-derived cells.
We are passionate about new technologies that can improve human health. We believe that by making disruptive technologies available to drug developers around the globe, new therapies will become available to patients at a faster pace.
- Industry Biotechnology
- Website https://www.saguarobio.com/
- LinkedIn https://www.linkedin.com/company/saguarobio/
Iceotope | $26,000,000 | (May 15, 2026)
Harken Sweets | Undisclosed Amount | (May 15, 2026)
Graphon AI | $8,300,000 | (May 15, 2026)
Ranger AI | $8,400,000 | (May 15, 2026)
Wirestock | $23,000,000 | (May 15, 2026)
GridCARE | $64,000,000 | (May 15, 2026)
Chromie Health | $2,000,000 | (May 15, 2026)
Novella | $21,000,000 | (May 15, 2026)
Flick | $6,000,000 | (May 15, 2026)
Synthetic | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Urologic Health | $11,000,000 | (May 14, 2026)